New permanent tax exclusions and expanded funds usage give benefit leaders the opportunity to bolster their financial ...

Loblaw Companies Limited ( OTCPK:LBLCF) Q2 2025 Earnings Conference Call July 24, 2025 10:00 AM ET Richard Dufresne - CFO & Member of Management Board Roy MacDonald - Vice President of Investor ...

The U.S. Food & Drug Administration (FDA) has approved certain GLP-1 drugs for commercialization and use, including liraglutide ...

Novo Nordisk announced it is cutting ties with telehealth giant Hims & Hers Health, pulling its blockbuster drug Wegovy from ...

The largest healthcare stocks by market capitalization are undergoing significant sell-offs. UnitedHealth is still a large ...

Dr Bryan Betty joined Jack Tame to discuss Wegovy – what it is, how you use it, the side effects, and why people are seeking medical treatment for their weight. A once-weekly injection for weight loss ...

The preventative healthcare measures recommended in the Scotland’s Population Health Framework 2025-2035 plan have been ...

The following is a special feature from CivicScience CEO and Founder John Dick. Learn how you can turn insights like these ...

Fractyl Health offers a high-risk, high-reward setup with a near-term binary catalyst in the REMAIN-1 cohort data expected Q3 ...

Over the coming years, the Inflation Reduction Act aims to help those with Medicare save on their prescription drug costs. Learn more.

Sustainability awareness remains strong in the Middle East, with 75% of respondents expressing concern about climate change.

Hims & Hers Health, Inc. (NYSE:HIMS) is among the 13 Best Booming Stocks to Buy Now. On July 9, the digital health and wellness platform announced plans to expand in Canada by offering generic ...